MERCK KGAA
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1668-01-01
- Employees
- 62.9K
- Market Cap
- $84.2B
- Website
- http://www.merckgroup.com/de
A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)
- Conditions
- Interventions
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 7
- Registration Number
- NCT03387046
- Locations
- 🇮🇹
Ospedale P.A.Micone, Genova, Italy
🇮🇹Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza, Roma, Italy
🇮🇹Ospedale Binaghi, Università di Cagliari,ASL 8, Cagliari, Italy
Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 9
- Registration Number
- NCT03387059
- Locations
- 🇮🇹
Centro di Procreazione Assistita Demetra, Firenze, Italy
🇮🇹Humanitas Fertility Center, Milano, Italy
🇮🇹Centro di Procreazione Medicalmente Assistita - Ospedale di Versilia, Lucca, Italy
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 485
- Registration Number
- NCT03369665
- Locations
- 🇧🇪
Clinique Saint Pierre, Ottignies, Belgium
🇬🇷Athens Medical Centre, Athens, Greece
🇭🇺Semmelweis Egyetem AOK, Budapest, Hungary
Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 270
- Registration Number
- NCT03364036
- Locations
- 🇦🇺
Liverpool Hospital, Sydney, New South Wales, Australia
🇭🇺Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpo, Szeged, Hungary
🇮🇱Rambam MC, Haifa, Israel
ATRi Transition Rollover Study
- First Posted Date
- 2017-10-13
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 1
- Registration Number
- NCT03309150
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule
- First Posted Date
- 2017-09-29
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 18
- Registration Number
- NCT03297983
- Locations
- 🇩🇪
Nuvisan GmbH, Neu-Ulm, Bavaria, Germany
First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants
- First Posted Date
- 2017-08-25
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 88
- Registration Number
- NCT03261401
- Locations
- 🇦🇺
Q-Pharm Pty Ltd, Brisbane, Australia
Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants
- Conditions
- Interventions
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 32
- Registration Number
- NCT03226275
- Locations
- 🇨🇳
Xuanwu Hospital, Beijing, China
First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2019-05-02
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 54
- Registration Number
- NCT03224702
- Locations
- 🇩🇰
DanTrials ApS c/o Bispebjerg Hospital, Copenhagen, Denmark
TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and Assessment
- Conditions
- Interventions
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 408
- Registration Number
- NCT03164551
- Locations
- 🇮🇹
Demetra S.R.L, Firenze, Italy
🇩🇰Skive Fertility clinic, Skive, Denmark
🇩🇰Fertility Clinic Skive Regional Hospital, Skive, Denmark